Quantitative Photoacoustic Imaging of Nanoparticles in Cells and Tissues

被引:62
作者
Cook, Jason R. [1 ]
Frey, Wolfgang [1 ]
Emelianov, Stanislav [1 ]
机构
[1] Univ Texas Austin, Dept Biomed Engn, Austin, TX 78712 USA
基金
美国国家卫生研究院;
关键词
nanoparticle; quantitative photoacoustic imaging; photoacoustic microscopy; histology; molecular sensing; cancer; IN-VIVO; CONTRAST AGENTS; GOLD NANOPARTICLES; SENSITIVITY; TOMOGRAPHY; ULTRASOUND; CANCER;
D O I
10.1021/nn304739s
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Quantitative visualization of nanoparticles in cells and tissues, while preserving the spatial information, is very challenging. A photoacoustic imaging technique to depict the presence and quantity of nanoparticles is presented. This technique is based on the dependence of the photoacoustic signal on both the nanoparticle quantity and the laser fluence. Quantitative photoacoustic imaging is a robust technique that does not require knowledge of the local fluence, but a relative change in the fluence. This eliminates the need for sophisticated methods or models to determine the energy distribution of light in turbid media. Quantitative photoacoustic imaging was first applied to nanoparticle-loaded cells, and quantitation was validated by inductively coupled plasma mass spectrometry. Quantitative photoacoustic imaging was then extended to xenograft tumor tissue sections, and excellent agreement with traditional histopathological analysis was demonstrated. Our results suggest that quantitative photoacoustic imaging may be used in many applications including the determination of the efficiency and effectiveness of molecular targeting strategies for cell studies and animal models, the quantitative assessment of photoacoustic contrast agent biodistribution, and the validation of in vivo photoacoustic imaging.
引用
收藏
页码:1272 / 1280
页数:9
相关论文
共 33 条
[1]   Targeted gold nanorod contrast agent for prostate cancer detection by photoacoustic imaging [J].
Agarwal, A. ;
Huang, S. W. ;
O'Donnell, M. ;
Day, K. C. ;
Day, M. ;
Kotov, N. ;
Ashkenazi, S. .
JOURNAL OF APPLIED PHYSICS, 2007, 102 (06)
[2]   Pushing the Sensitivity Envelope of Lanthanide-Based Magnetic Resonance Imaging (MRI) Contrast Agents for Molecular Imaging Applications [J].
Aime, Silvio ;
Castelli, Daniela Delli ;
Crich, Simonetta Geninatti ;
Gianolio, Eliana ;
Terreno, Enzo .
ACCOUNTS OF CHEMICAL RESEARCH, 2009, 42 (07) :822-831
[3]   MR molecular imaging of the Her-2/neu receptor in breast cancer cells using targeted iron oxide nanoparticles [J].
Artemov, D ;
Mori, N ;
Okollie, B ;
Bhujwalla, ZM .
MAGNETIC RESONANCE IN MEDICINE, 2003, 49 (03) :403-408
[4]   Gold Nanoprisms as Optoacoustic Signal Nanoamplifiers for In Vivo Bioimaging of Gastrointestinal Cancers [J].
Bao, Chenchen ;
Beziere, Nicolas ;
del Pino, Pablo ;
Pelaz, Beatriz ;
Estrada, Giovani ;
Tian, Furong ;
Ntziachristos, Vasilis ;
de la Fuente, Jesus M. ;
Cui, Daxiang .
SMALL, 2013, 9 (01) :68-74
[5]   Optical-based molecular imaging: contrast agents and potential medical applications [J].
Bremer, C ;
Ntziachristos, V ;
Weissleder, R .
EUROPEAN RADIOLOGY, 2003, 13 (02) :231-243
[6]   Photoacoustic tomography of joints aided by an Etanercept-conjugated gold nanoparticle contrast agent -: an ex vivo preliminary rat study [J].
Chamberland, David L. ;
Agarwal, Ashish ;
Kotov, Nicholas ;
Fowlkes, J. Brian ;
Carson, Paul L. ;
Wang, Xueding .
NANOTECHNOLOGY, 2008, 19 (09)
[7]  
Choy Garry, 2003, Mol Imaging, V2, P303, DOI 10.1162/153535003322750646
[8]   Tissue-mimicking phantoms for photoacoustic and ultrasonic imaging [J].
Cook, Jason R. ;
Bouchard, Richard R. ;
Emelianov, Stanislav Y. .
BIOMEDICAL OPTICS EXPRESS, 2011, 2 (11) :3193-3206
[9]   Bioconjugated gold nanoparticles as a molecular based contrast agent: Implications for imaging of deep tumors using optoacoustic tomography [J].
Copland, JA ;
Eghtedari, M ;
Popov, VL ;
Kotov, N ;
Mamedova, N ;
Motamedi, M ;
Oraevsky, AA .
MOLECULAR IMAGING AND BIOLOGY, 2004, 6 (05) :341-349
[10]   Molecular imaging of cancer with positron emission tomography [J].
Gambhir, SS .
NATURE REVIEWS CANCER, 2002, 2 (09) :683-693